SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹1.66 Cr | ₹1.66 Cr | ₹1.66 Cr | ₹1.66 Cr | ₹1.66 Cr |
What is the latest Capital Work in Progress ratio of SHUKRA PHARMACEUTICALS ?
Year | Capital Work in Progress |
---|---|
Mar2023 | ₹1.66 Cr |
Mar2022 | ₹1.66 Cr |
Mar2021 | ₹1.66 Cr |
Mar2020 | ₹1.66 Cr |
Mar2019 | ₹1.66 Cr |
How is Capital Work in Progress of SHUKRA PHARMACEUTICALS Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2023 | ₹1.66 Cr | 0.00 | |
Mar2022 | ₹1.66 Cr | 0.00 | |
Mar2021 | ₹1.66 Cr | 0.00 | |
Mar2020 | ₹1.66 Cr | 0.00 | |
Mar2019 | ₹1.66 Cr | - |
Compare Capital Work in Progress of peers of SHUKRA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHUKRA PHARMACEUTICALS | ₹477.7 Cr | -7.8% | 19.1% | 489.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹351,910.0 Cr | -4.8% | -3.5% | 59.7% | Stock Analytics | |
CIPLA | ₹119,369.0 Cr | 2.4% | 5.2% | 59.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹112,930.0 Cr | 5.9% | 10.8% | 21.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,515.0 Cr | -2.8% | 11.3% | 112.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,161.7 Cr | 1.8% | -5.4% | 31.5% | Stock Analytics |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHUKRA PHARMACEUTICALS | -7.8% |
19.1% |
489.5% |
SENSEX | 1.9% |
2.1% |
21.7% |
You may also like the below Video Courses